Ne

Neoplasia

Neoplasia is an open access oncology journal that publishes novel investigations across all areas of cancer research, including molecular and genetic findings related to the neoplastic phenotype as well as laboratory and clinical studies on risk assessment, prognostic indications, detection, diagnosis, and treatment. The journal publishes Research Reports, Reviews, and Meeting Reports and emphasizes thorough, fair, and rapid review and publication.

Looking to publish in Neoplasia? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Oncology
Impact Factor 7.7
Quartile Q1
Open Access Type Open
ISSN 1476-5586
eISSN 1476-5586
Invitation Only No
Cost Range Article Publishing Charge: USD 3790 excluding taxes for all articles.

Submission Instructions

Neoplasia accepts the following article types. Click on an article type to view submission instructions.

Original Research Article

Cover Letter Cover Letter requirements are not specified.
Abstract A structured abstract is required. Abstract must not exceed 250 words. Abstract must be structured.
Manuscript Manuscript must not exceed 4,500 words. Manuscript must be divided into Introduction, Materials and Methods, Results, and Discussion sections. Manuscript must include 1 to 6 English keywords, and if generative AI was used in manuscript preparation, a declaration section must be placed immediately before the references.
References Reference list must contain no more than 50 references. References may be formatted in any consistent style or format at submission. References must include author names, source title information, year, and volume with article number or pagination where applicable, and every in-text citation must appear in the reference list and vice versa.
Figures & Tables The total number of figures and/or tables must not exceed 6. Figures must be uploaded as separate files, whereas tables must be provided as editable text. All figures and tables must be cited in the text, numbered consecutively in order of appearance, and accompanied by captions.
Reformat to Neoplasia using Livewrite Premium

Review Article

Cover Letter Cover Letter requirements are not specified.
Abstract A short abstract is required for Review Articles. Abstract must not exceed 250 words. Abstract must state the goal of the review.
Manuscript Manuscript must not exceed 4,500 words. Manuscript must include an introduction, discussion, and conclusion, and be divided into clearly defined sections with headings. Manuscript must include 1 to 6 English keywords and, if AI tools were used in manuscript preparation, a declaration section immediately before the references specifying the tool used and the reason for using it.
References Reference list must contain no more than 80 references. References may be submitted in any consistent style or format. References cited in the text must appear in the reference list and vice versa, and each reference must include author names, title, year, and journal or book details with volume and pagination or article number where applicable.
Figures & Tables The total number of figures and/or tables must not exceed 6. Figures must be uploaded as separate files, while tables must be submitted as editable text. All figures and tables must be cited in the text, numbered in order of appearance, and provided with captions.
Reformat to Neoplasia using Livewrite Premium

Letters To The Editors

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract should not be included for Letters To The Editors.
Manuscript Manuscript must not exceed 1,000 words. Manuscript must be divided into clearly defined sections using headings. No more than 3 authors are permitted without prior editorial approval.
References References must be limited to no more than 10. References may be submitted in any consistent style or format. References must include author names, source title, article or chapter title, year, and volume, article number, or page range where applicable.
Figures & Tables Figures and/or tables must be limited to 1 in total. Figures must be uploaded as separate files, whereas tables must be submitted as editable text. All figures and tables must be cited in the text, numbered consecutively, and accompanied by captions.
Reformat to Neoplasia using Livewrite Premium

Recent Publications

Cancer-associated fibroblast-derived protein S100-A11 influences the response to anti-HER2 therapies in HER2-positive breast cancer

Melani Luque, Miriam Morales-Gallego, Marta Sanz-Álvarez, Claudia Arguiñano, Yamileth Rangel, Natalia Ramírez-Merino, Mengjuan Qin, Ana Rovira, Joan Albanell, Juan Madoz-Gúrpide, Federico Rojo

10.1016/j.neo.2026.101318
View Publication

Quantitative dissection of radioresistance in cancer cells: Oxygen depletion-induced biological versus chemical mechanisms and baseline mechanisms governed by HIF-1β-NRF2/TXNRD1

Satoshi Takeuchi, Minoru Kobayashi, Peter Wai Tik Lee, Itsuki Takahashi, Toshitada Yoshihara, Hiroshi Harada

10.1016/j.neo.2026.101317
View Publication

A MYC family switch: L-MYC drives and maintains neuroendocrine lineage programs in prostate cancer

Jeyaluxmy Sivalingam, Kaleigh Ballagh, Kyung Hyun Cho, Yingli Shi, Lin Li, Preston Barron, Michael S. Lan, Omar E Franco, Xiuping Yu

10.1016/j.neo.2026.101307
View Publication

Characterizing the impact of MLL fusion variants and fusion partners on leukemia plasticity using a human CRISPR-engineered MLL-rearranged leukemia model

Pia Radszuweit, Rahel Fitzel, Sarah Bruestl, Thomas Hentrich, Fulya Korkmaz, Barbara Mankel, Irene González-Menéndez, Saskia Rudat, Rolf Marschalek, Estelle Erkner, Hildegard Keppeler, Rebekka Schairer, Luise Luib, Markus Mezger, Leticia Quintanilla-Martinez, Julia Schulze-Hentrich, Claudia Lengerke, Dominik Schneidawind, Corina Schneidawind

10.1016/j.neo.2026.101308
View Publication

From inflammation to malignancy: the dynamic evolution of cancer-associated fibroblasts in IBD-CRC

Nobuhiro Naito, Hiroaki Kasashima, Tatsunari Fukuoka, Yuki Nakanishi, Naoko Ohtani, Kiyoshi Maeda

10.1016/j.neo.2026.101310
View Publication

Frequently asked questions

How long does it take to publish?

3 days from submission to first decision; 57 days from submission to decision after review; 80 days from submission to acceptance; 9 days from acceptance to online publication.

Reformat to Neoplasia using Livewrite Premium

What are the publication costs?

Article Publishing Charge: USD 3790 excluding taxes for all articles.

Reformat to Neoplasia using Livewrite Premium

Research Topics

Cancer, Hypoxia, and Metabolism Cancer-related Molecular Pathways Cancer Cells and Metastasis Epigenetics and DNA Methylation Angiogenesis and VEGF in Cancer Prostate Cancer Treatment and Research Ubiquitin and proteasome pathways Glioma Diagnosis and Treatment Cell Adhesion Molecules Research Cancer Genomics and Diagnostics Cancer-related gene regulation Pancreatic and Hepatic Oncology Research RNA modifications and cancer Immune cells in cancer PI3K/AKT/mTOR signaling in cancer Cancer Research and Treatments DNA Repair Mechanisms Cancer Immunotherapy and Biomarkers Immunotherapy and Immune Responses Cancer-related molecular mechanisms research Cancer, Lipids, and Metabolism Cell death mechanisms and regulation Neuroblastoma Research and Treatments Peptidase Inhibition and Analysis Cytokine Signaling Pathways and Interactions

Related Journals

JO
Journal Of Autoimmunity Elsevier BV
BC
Blood Cancer Journal Springer Nature
MM
Molecular Metabolism Elsevier BV
TA
Ticks And Tick-borne Diseases Elsevier BV
JE
Jacc-clinical Electrophysiology Elsevier BV
Id
Idcases Elsevier BV